0001777474-19-000001.txt : 20190522 0001777474-19-000001.hdr.sgml : 20190522 20190522103744 ACCESSION NUMBER: 0001777474-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190522 DATE AS OF CHANGE: 20190522 EFFECTIVENESS DATE: 20190522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Veralox Therapeutics Inc. CENTRAL INDEX KEY: 0001777474 IRS NUMBER: 823072071 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-340135 FILM NUMBER: 19844589 BUSINESS ADDRESS: STREET 1: 4539 METROPOLITAN COURT CITY: FREDERICK STATE: MD ZIP: 21704 BUSINESS PHONE: (301) 360-3502 MAIL ADDRESS: STREET 1: 4539 METROPOLITAN COURT CITY: FREDERICK STATE: MD ZIP: 21704 D 1 primary_doc.xml X0708 D LIVE 0001777474 Veralox Therapeutics Inc. 4539 METROPOLITAN COURT FREDERICK MD MARYLAND 21704 (301) 360-3502 DELAWARE None None Corporation true 2018 Jeffrey W. Strovel 4539 Metropolitan Court Frederick MD MARYLAND 21704 Executive Officer Director Matthew Boxer 4539 Metropolitan Court Frederick MD MARYLAND 21704 Executive Officer Director David Maloney 4539 Metropolitan Court Frederick MD MARYLAND 21704 Executive Officer Director Jonathan Behr 50 Milk Street, 16th Floor Boston MA MASSACHUSETTS 02109 Director Biotechnology Decline to Disclose 06b false 2019-05-10 false true false 25000 4000000 1460000 2540000 false 6 0 0 0 false Veralox Therapeutics Inc. /s/Jeffrey W. Strovel Jeffrey W. Strovel CEO 2019-05-22